We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IBM Watson Introduces Cognitive Imaging to Boost Healthcare
Read MoreHide Full Article
International Business Machines Corporation (IBM - Free Report) recently launched IBM Watson Imaging Clinical Review, a cognitive imaging offering, which happens to be the first of its kind from the Watson Health stable, at the Health IT Conference for 2017.
Additionally, the company announced that the Watson Health medical imaging collaborative has been expanded to 24 organizations globally to address eye, heart, brain, breast and related conditions further.
IBM’s cognitive imaging offering will initially address cardiovascular diseases such as aortic stenosis which currently affects nearly 1.5 million people in the U.S. IBM intends to expand the coverage to nine additional cardiovascular conditions such as valve disorders, deep vein thrombosis, cardiomyopathy (a heart muscle disease) and myocardial infractions (heart attacks) in the long run.
International Business Machines Corporation Price and Consensus
The Watson Health Imaging Clinical Review was designed by the members of the Watson Health medical imaging collaborative that comprises of academic medical centers, private radiology practices, leading health systems, imaging technology companies and ambulatory radiology providers.
The objective of the cognitive imaging offering is to utilize medical imaging techniques to identify as well as predict the chances of getting affected with diseases such as cancer, eye diseases, diabetes and other diseases related to the heart, brain and other related conditions.
It utilizes cognitive text analytics to verify whether the doctor’s remarks regarding a particular patient were entered into the electronic health record (EMR), the diagnosis list and the billing records.
IBM’s cognitive imaging offering is a targeted artificial intelligence tool that has the potential to help the healthcare providers standardize their healthcare services and build a database of patient data which could be utilized to enhance their healthcare offerings.
Moreover, the cognitive imaging solution is capable of enabling the healthcare providers to gain enhanced insights into the patient condition and provide better and personalized care.
What Does this Mean for IBM?
Per an IDC report, worldwide spending on cognitive systems and artificial intelligence is expected to reach over $47 billion by 2020 which is currently growing at a CAGR of 55.1%.
Given the huge opportunity the sector has to offer, there is fierce competition in the space with the presence of major players such as Microsoft (MSFT - Free Report) , Google (GOOGL - Free Report) and Apple.
However, we believe that IBM is well positioned to take on the competition head on and such introductions are a step in the right direction that augur well in the long run.
Stock Performance Overview
Shares of IBM have underperformed the Zacks Computer - Integrated Systems industry over the last one year. While the industry gained 40.2%, the stock appreciated only 31.2%.
The underperformance of the stock could be attributed to the transition to the cloud, weakness in traditional businesses, lower IT spending, integration risks and increasing competition.
However, the company’s strategic growth initiatives such as cognitive solutions, cloud computing, mobile and social businesses are expected to drive growth in the coming years.
Notably, the Zacks Consensus Estimate for Digi International’s current year has improved to 43 cents from 42 cents in the last 60 days.
Zacks' Top Investment Ideas for Long-Term Profit
How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
IBM Watson Introduces Cognitive Imaging to Boost Healthcare
International Business Machines Corporation (IBM - Free Report) recently launched IBM Watson Imaging Clinical Review, a cognitive imaging offering, which happens to be the first of its kind from the Watson Health stable, at the Health IT Conference for 2017.
Additionally, the company announced that the Watson Health medical imaging collaborative has been expanded to 24 organizations globally to address eye, heart, brain, breast and related conditions further.
IBM’s cognitive imaging offering will initially address cardiovascular diseases such as aortic stenosis which currently affects nearly 1.5 million people in the U.S. IBM intends to expand the coverage to nine additional cardiovascular conditions such as valve disorders, deep vein thrombosis, cardiomyopathy (a heart muscle disease) and myocardial infractions (heart attacks) in the long run.
International Business Machines Corporation Price and Consensus
International Business Machines Corporation Price and Consensus | International Business Machines Corporation Quote
How Cognitive Imaging Works?
The Watson Health Imaging Clinical Review was designed by the members of the Watson Health medical imaging collaborative that comprises of academic medical centers, private radiology practices, leading health systems, imaging technology companies and ambulatory radiology providers.
The objective of the cognitive imaging offering is to utilize medical imaging techniques to identify as well as predict the chances of getting affected with diseases such as cancer, eye diseases, diabetes and other diseases related to the heart, brain and other related conditions.
It utilizes cognitive text analytics to verify whether the doctor’s remarks regarding a particular patient were entered into the electronic health record (EMR), the diagnosis list and the billing records.
IBM’s cognitive imaging offering is a targeted artificial intelligence tool that has the potential to help the healthcare providers standardize their healthcare services and build a database of patient data which could be utilized to enhance their healthcare offerings.
Moreover, the cognitive imaging solution is capable of enabling the healthcare providers to gain enhanced insights into the patient condition and provide better and personalized care.
What Does this Mean for IBM?
Per an IDC report, worldwide spending on cognitive systems and artificial intelligence is expected to reach over $47 billion by 2020 which is currently growing at a CAGR of 55.1%.
Given the huge opportunity the sector has to offer, there is fierce competition in the space with the presence of major players such as Microsoft (MSFT - Free Report) , Google (GOOGL - Free Report) and Apple.
However, we believe that IBM is well positioned to take on the competition head on and such introductions are a step in the right direction that augur well in the long run.
Stock Performance Overview
Shares of IBM have underperformed the Zacks Computer - Integrated Systems industry over the last one year. While the industry gained 40.2%, the stock appreciated only 31.2%.
The underperformance of the stock could be attributed to the transition to the cloud, weakness in traditional businesses, lower IT spending, integration risks and increasing competition.
However, the company’s strategic growth initiatives such as cognitive solutions, cloud computing, mobile and social businesses are expected to drive growth in the coming years.
Zacks Rank
At present, IBM carries a Zacks Rank #3 (Hold).
A better-ranked stock in the broader technology space is Digi International Inc. (DGII - Free Report) carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Notably, the Zacks Consensus Estimate for Digi International’s current year has improved to 43 cents from 42 cents in the last 60 days.
Zacks' Top Investment Ideas for Long-Term Profit
How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>